Selank

Approved (Russia/Ukraine)

Selank (TP-7)

Aliases
TP-7, Selanc
Administration
Intranasal spray, Subcutaneous injection

Research and regulatory

Development stage

Approved anxiolytic/nootropic in Russia and Ukraine; research compound in most other jurisdictions.

Legal and regulatory

Prescription drug in Russia/Ukraine; unscheduled research compound elsewhere.

Side effects

Mild fatigue; excellent safety profile